Governance overview
The Board of Directors of UroGen® Pharma (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
Committee compositions
| Director Name | Audit Committee | Compensation Committee | Compliance Committee | Nominating and Corporate Governance Committee |
|---|---|---|---|---|
| Arie Belldegrun, M.D. | of the Compensation CommitteeCompensation Committee | |||
| Cynthia M. Butitta | of the Audit CommitteeAudit Committee | |||
| Fred E. Cohen, M.D. | of the Compensation CommitteeCompensation Committee | |||
| Stuart Holden, M.D. | of the Audit CommitteeAudit Committee | of the Compliance Committee Compliance Committee | ||
| Jim Robinson | of the Compliance Committee Compliance Committee | of the Nominating and Corporate Governance CommitteeNominating and Corporate Governance Committee | ||
| Leana S. Wen, M.D., M.Sc. | of the Audit CommitteeAudit Committee | of the Nominating and Corporate Governance CommitteeNominating and Corporate Governance Committee | ||
| Daniel Wildman | of the Compensation CommitteeCompensation Committee | of the Compliance Committee Compliance Committee |
Chairperson icon
=
Chairperson
Member icon
=
Member
Financial Expert icon
=
Financial Expert
